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Abstract
Background: This paper presents the protocol for an ongoing study to evaluate a telemedicine follow-up intervention for patients
with diabetes-related foot ulcers. Diabetes-related foot ulcers represent challenges for patients and the health services. The large
increase in the prevalence of diabetes, combined with the aging population, means that the absolute number of patients with
diabetes-related foot ulcers is likely to continue to increase. Health care services therefore need to provide close clinical follow-up
care for people with diabetes both in primary and specialist care. Information and communication technologies may enable more
integrated treatment and care pathways across organizational boundaries. However, we lack knowledge about the effect of
telemedicine follow-up and how such services can be optimally organized.
Objective: To present the design and methods of a study evaluating a telemedicine follow-up intervention for patients with
diabetes-related foot ulcers.
Methods: The study is designed as a cluster randomized controlled trial (noninferiority trial) involving municipalities or
municipality districts (clusters) belonging to one clinical site in Western Norway. The study includes patients with type 1 and
type 2 diabetes presenting with a new foot ulcer at the initial visit to the clinic. Patients in the intervention group receive telemedicine
follow-up care in the community. The key ingredient in the intervention is the close integration between health care levels. The
intervention is facilitated by the use of an interactive wound platform consisting of a Web-based ulcer record combined with a
mobile phone, enabling counseling and communication between nurses in the community and specialist health care. Patients in
the control group receive standard hospital outpatient care. The primary endpoint in the trial is healing time; secondary outcomes
include amputation and death, patient-reported outcome measures, and follow-up data on the recurrence of foot ulcers. In addition,
qualitative substudies are being performed to provide a more comprehensive evaluation of the ongoing processes during the trial
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with the patients in the intervention and control groups and those health care professionals either working in primary care or in
specialist care delivering the intervention.
Results: The project has been funded. The inclusion of patients started in September 2012. Because recruitment goals were not
met in the initial period, two more clinical sites have been included to meet sample size requirements. Patient recruitment will
continue until June 2016. Data collection in the qualitative substudies has been completed.
Conclusions: This telemedicine trial operates in a novel setting and targets patients with diabetes-related foot ulcers during a
12-month follow-up period. The trial addresses whether integrated care using telemedicine between primary and specialist health
care can be an equivalent alternative to standard outpatient care.
Trial Registration: ClinicalTrials.gov NCT01710774; https://clinicaltrials.gov/ct2/show/NCT01710774 (Archived by WebCite
at http://www.webcitation.org/6im6KfFov).
(JMIR Res Protoc 2016;5(3):e148)   doi:10.2196/resprot.5646
KEYWORDS
diabetes; diabetic foot; foot ulcer; telemedicine; randomized controlled trial; primary care; delivery of health care, integrated;
complex intervention; patient-reported outcomes; Norway; cluster RCT
Introduction
Background
The prevalence of diabetes is expected to increase both in
Norway and globally [1]. In Norway, about 200,000 people
have been diagnosed with diabetes [2] with an annual increase
of 8000 to 10,000 forecast. In addition, an estimated 150,000
people have undiagnosed type 2 diabetes [2,3]. The increasing
prevalence of diabetes, especially type 2 diabetes, combined
with an increasing proportion of older people in the population
present great challenges for the health care services [2,4,5]. An
epidemiologic study of diabetes-related foot ulcers among
community-dwelling adults and older people based on data from
the Nord-Trøndelag Health Study (HUNT2) showed that a
history of foot ulcer was significantly associated with increased
mortality and that about 10% of people with diabetes reported
a history of foot ulcer [6-8]. Other studies have shown that a
foot ulcer is associated with reduced quality of life, social
limitations, and pain [9]. The cost of treating foot ulcers is also
considerable [10]. It is therefore important to start treatment
early and have a close, well-organized follow-up for patients
with diabetes-related foot ulcers to improve the management
of the diabetic foot [11].
State of the Evidence, Relevance, and Innovation
Potential
The main goal for the Norwegian Coordination Reform in the
health care sector in January 2012 was to obtain coordinated
and integrated health care for patients, especially for those with
complex conditions [12]. In this reform, electronic
communication and use of telemedicine is emphasized.
Qualitative studies of diabetes-related foot ulcers [13-15] have
shown that using telemedicine can result in follow-up care of
similar quality to standard outpatient care while at the same
time enabling more flexible organization and greater patient
satisfaction. Patients with diabetes foot ulcers are prone to
adverse outcomes because of rapid deterioration of the ulcer or
the onset of infection. To date, randomized controlled studies
have not confirmed that telemedicine follow-up care for patients
with diabetes-related foot ulcers results in equivalent healing
time when compared with standard outpatient care in specialist
health care [16,17]. Therefore, there is a need for such studies
to document the safety and effectiveness of a telemedicine-based
follow-up. This project is expected to increase the focus on
research related to integrated care [3,12].
This paper presents the protocol for an ongoing cluster
randomized controlled noninferiority trial, DiaFOTo (Diabetic
Foot and Telemedical Images Project). The trial is designed to
compare the effect of telemedicine follow-up in primary care
to standard hospital outpatient care on ulcer healing time. In
addition, qualitative data were collected to evaluate ongoing
processes and further elaborate the experiences of patients and
health care professionals during the intervention period. These
qualitative studies are part of a larger program supported by the
Norwegian Research Council (DiaHEALTH-221065/F40) to
promote patient and professional competencies in diabetes care
and management.
Aims and Research Questions
The main aim of this trial is to evaluate whether follow-up of
patients with diabetes-related foot ulcers in primary care, in
collaboration with hospital outpatient specialist care, is
noninferior to standard outpatient care in terms of ulcer healing
time.
Our primary research question is whether healing time (within
12 months) of diabetes-related foot ulcers treated in primary
care in collaboration with telemedicine consultations with a
hospital outpatient is no worse than with standard hospital
outpatient care. The corresponding null hypothesis: mean
difference in healing time is 1.5 months or less for
diabetes-related foot ulcers with telemedicine follow-up in
primary care, compared to standard hospital outpatient care.
We will also evaluate whether the incidence of amputation and
mortality, sickness absence, clinical measures (number of
consultations, complications directly related to the foot ulcer
as indicated by use of antibiotics), recurrence of a new foot
ulcer (within 48 months), and patient-reported outcome
measures (PROMs) are different for telemedicine follow-up in
primary care compared with standard hospital outpatient care.
We conducted supplementary qualitative studies to provide a
more comprehensive description and evaluation of the ongoing
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processes during the intervention. Individual interviews with
patients in the intervention and control groups aimed to explore
patient experiences with telemedicine follow-up or standard
outpatient care delivered in the DiaFOTo trial. Focus group
interviews with health care professionals either working in
primary care or in specialist care delivering the intervention
aimed to explore health care professional experiences when




In this pragmatic randomized controlled trial (RCT) [18], we
evaluate the effectiveness of the intervention on patient health
using the Model for Assessment of Telemedicine criteria [19]
and the complex intervention framework developed by the
Medical Research Council in the United Kingdom [20]. We
used a noninferiority parallel cluster design. The flow and
attrition diagram is shown in Figure 1 and based on the
CONSORT 2010 statement: extension to cluster randomized
trials [21]. Reporting will adhere to the guidelines of the
Consolidated Standards for Reporting Trials (CONSORT) [22].
The trial is in accordance with the CONSORT EHEALTH
checklist [23]. The study has been registered with
ClinicalTrials.gov [NCT01710774].
Quantitative data are being collected at the time of inclusion
(baseline) after informed consent has been obtained and before
randomization (t1), and the patient is monitored every second
week until the foot ulcer has either healed or until the end of
follow-up (maximum 12 months after baseline) (t2). Additional
information will be retrieved 36 months after the initial
follow-up period about the occurrence of new foot ulcers,
amputation, or death. Maximum follow-up for each patient is
therefore 48 months.
Figure 1. Flow diagram of clusters and patients in the cluster randomized controlled noninferiority trial, DiaFOTo.
Trial Population and Recruitment
We are currently including all patients with diabetes-related
foot ulcers from the southern part of Rogaland County referred
to the endocrinology unit of Stavanger University Hospital
(Stavanger HF) between September 2012 and June 2016 at the
initial visit to the clinic.
The trial includes patients with type 1 or type 2 diabetes if they
are 20 years or older and present a new foot ulcer to the clinical
JMIR Res Protoc 2016 | vol. 5 | iss. 3 | e148 | p.3http://www.researchprotocols.org/2016/3/e148/
(page number not for citation purposes)
Iversen et alJMIR RESEARCH PROTOCOLS
XSL•FO
RenderX
site. A foot ulcer is defined as a skin lesion below the ankle on
a diabetic foot. The exclusion criteria include (1) an ulcer on
the same foot treated during the past 6 months in specialist
health care (because chronic ulcers can interfere with the
primary outcome in the study protocol); (2) mental disorders
or cognitive impairment (including schizophrenia, other
psychotic disorders, and dementia); (3) inability to complete
questionnaires in Norwegian, or (4) life expectancy of less than
1 year. Patients are being assessed for primary diagnosis and
treatment at the clinical site according to standard protocols
based on national guidelines [3].
Randomization and Blinding
The southern part of Rogaland County in the western part of
Norway was divided into 26 clusters based on municipalities
or districts within municipalities. These were matched in pairs
according to population size and rural/urban characteristics.
Within each of the 13 pairs, the two clusters were randomly
allocated to intervention or standard treatment. The
randomization sequences were generated by an independent
person using SPSS version 21 statistical software (IBM Corp).
All patients in each cluster/municipality are in the same
treatment group. All participants are informed by the study
nurse about the allocated type of treatment after enrollment in
the study and after providing baseline data. The intervention is
designed to evaluate a change in health service provision;
therefore blinding of the intervention is not possible. The study
staff monitors whether pictures are submitted as planned and
follows up to ensure compliance. We also assess how closely
the nurses follow the protocol. The outcome is assessed by
health care professionals at the outpatient clinics, who are not
blinded to study arm but are trained to follow and assess wounds
using a standardized protocol. The numbers of patients who do
not meet the inclusion criteria, decline to participate, or drop
out of the trial are recorded by age and gender.
Development of the Intervention
The intervention consists of a Web-based ulcer record to
facilitate asynchronous communication between primary and
specialist health care and includes a database and an application
to communicate images and text between participants. The
Web-based ulcer record (Dansk Telemedicin AS) has been
adapted to Norwegian legislation and is described in a previous
publication [24]. We carried out a preliminary project in spring
2011 to develop and adjust the telemedicine tools to patients
with diabetes-related foot ulcers receiving care in the
community. In a pilot project between autumn 2011 and spring
2012, the data collection forms and telemedicine tools were
tested on five patients. A standard procedure protocol was
developed in brochure form to ensure that photographic
documentation of ulcers was taken at optimal resolution, with
adequate lighting and good contrast, from specified angles. The
brochure also included instructions for use of the Web-based
ulcer record, the integrated infrastructure, and legal and data
security aspects.
Telemedicine Intervention
Patients in the intervention group receive telemedicine follow-up
care in the community. The key ingredient in the intervention
is the close integration between health care levels. The
intervention is facilitated by the use of an interactive wound
platform consisting of a Web-based ulcer record combined with
a mobile phone, enabling counseling and communication
between nurses in the community and specialist health care.
Foot ulcer data including images are sent by mobile phone to
the Web-based ulcer record for asynchronous consultation with
specialist health care. Images are recorded throughout the trial,
stored in the Web-based ulcer record, and transferred encrypted
to a server. General practitioners in the intervention group can
get access to the Web-based ulcer platform if required (Figure
2).
The nurses are trained to use the Web-based ulcer record and
mobile phone using written information. Individual teaching
and training of the nursing staff in primary care is offered at the
specialist clinic or in primary care to secure equivalent and
competent handling of patients. The diabetes specialist nurse
and/or podiatrist in the multidisciplinary project team provide
the latter. The written information also includes a section
defining the delegation of responsibility at each level of health
care providers with respect to the treatment of diabetic ulcers.
Follow-up procedures are set up for each participant. The nurses
review the images at the Web-based ulcer record and discuss
them with the specialists if there is any uncertainty. Nurses in
the specialist health care communicate with community care
nurses at least once a week. In addition, nurses in specialist
health care can check and contact community nurses on an
ongoing basis. Discussions are mainly about wound care but
could also include earlier referral if required. The home care
nurse or general practice nurse will initiate contact with
specialist health care regardless of prior agreements if the ulcers
do not improve or get worse.
We have not made important changes to the intervention or
control arm during the trial. Functionality has been evaluated
every year and minor adjustments have been performed;
however, this has not involved system failures/downtimes, etc.
We have used the same photo documentation
(smartphone/camera) throughout the project.
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Figure 2. Diagram illustrating the general use of the telemedicine tool.
Control Group
The control group receives standard hospital outpatient
consultations with health care professionals at the endocrinology
unit of Stavanger University Hospital. The medical treatment
given to the control and intervention group is based on the same
procedures. Foot ulcer data including images are recorded
throughout the trial but only at the outpatient clinic. Like in the
intervention group, the data are stored in the Web-based ulcer
record and transferred in encrypted form to the same server.
Evaluation Measures
The trial includes self-reported questionnaire data and
information collected from the electronic patient journal and
the clinical diabetes system at the outpatient clinic. The
quantitative measures in our trial are described in detail below.
Primary Outcome Measure
The primary outcome is healing time measured from the time
the person presents the ulcer at the clinical site (included in the
trial) until the foot ulcer is healed.
Secondary Outcome Measures
Time to amputation (foot, below, through, or above the knee)
and death during the patient follow-up period as well as
self-reported questionnaire data will be used as secondary
outcome measures in this trial. This questionnaire package will
include standardized instruments measuring patient-reported
outcomes as problem areas in diabetes, quality of life, symptoms
of anxiety and depression, and satisfaction with treatment (see
Table 1 for details).
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t2Time to amputation. Data from electronic medical journals at the
clinical sites.
Amputation (before healing)
t2Time to death. Data from electronic medical journals at the clinical
sites.
Death (before healing)
t1, t2The World Health Organization well-being index (WHO-5). Scale
0-5; higher scores indicating greater emotional distress.
Well-being during the previous 2 weeks [25-27]
t1, t2Hospital Anxiety and Depression Scale (HADS). Two subscales,
0-3 (scored 0-21); higher scores indicate more symptoms.
Symptoms of anxiety and depression during the past week [28-30]
t1, t2Problem Areas in Diabetes (PAID). Scale 0-4 (scored 0-100);
higher scores indicate more problems.
Diabetes-related problem areas [31-33]
t1, t2Neuropathy- and Foot Ulcer–Specific Quality of Life Instrument
(NeuroQoL). Five subscales 1-5; higher scores indicate lower
quality of life.
Impact of diabetic peripheral neuropathy and foot ulcers on pa-
tient’s quality of life [34,35]
t1, t2Perceived health (or self-rated health). Scale 1-4; higher scores
indicate better perceived health.
Health status reflecting an individual’s subjective perception of
health conditions [36-38]
t1, t2Euro-Qol (EQ-5D-5L). Scale 1-5; 1 represents “no problem.”
Overall health, VAS-Scale, 0-100, higher scores indicate better
health.
Health-related problems and health related quality of life [39,40]
t1, t2Nordic Patient Experiences Questionnaire.Patient experiences [41]
t3Data from electronic medical journals at the clinical sites.The occurrence of new foot ulcers and amputation (after the initial
follow-up period)
t4Norwegian sick leave registry (FD-Trygd registry).Sickness absence
t4Time to death (months). Cause of death registry.Death (after the initial follow-up period)
Other measures
t1Patient questionnaire.Demographic characteristics (age, sex, ethnicity, education, cohab-
itation, marital status, working status and smoking, travel distance
to hospital)
t1, t2,Data from electronic medical journals at the clinical sites.Clinical data related to diabetes and diabetes foot ulcer
t2Number in specialist care and primary care.Consultations
t1, t2University of Texas Diabetic Wound Classification System.
Higher grade classified increasing wound depth (0-3). Higher stage
classified the presence of infection and/or ischemia (A-D).
Wound classification [42,43]
at1: baseline assessment, t2: end of the initial follow-up period, t3: 36 months after end of the initial follow-up period, t4: will be merged with registry
data after the trial is closed.
Long-term data on the time elapsing before a new foot ulcer
appears and the incidence of amputation will be collected for
36 months after the initial follow-up period from the electronic
patient journal at the clinical sites. Information on death (date
and cause) will be retrieved from the Norwegian Cause of Death
Registry.
Other Measures
We collect self-reported demographic data on age, sex, ethnicity,
education, cohabitation, marital status, working status, and
smoking status of the participant. In addition, clinical data are
collected. For all participants, we store a picture and measure
the wound area in the Web-based ulcer record system at the
time of inclusion in the trial, after 8 weeks, and at the end of
follow-up. The foot ulcers are classified according to the
University of Texas Diabetic Wound Classification System
[42], which combines grade and stage, is descriptive, and
predicts clinical outcomes well (risk of amputation and healing
time) [43]. At baseline, we collect data on blood pressure and
measurements of neuropathy. Biological data include
hemoglobin A1c concentration and measurements of renal
function (serum-creatinine, glomerular filtration rate, and
microalbuminuria). Data from the medical records include type
of diabetes, onset of diabetes, microvascular complications
JMIR Res Protoc 2016 | vol. 5 | iss. 3 | e148 | p.6http://www.researchprotocols.org/2016/3/e148/
(page number not for citation purposes)
Iversen et alJMIR RESEARCH PROTOCOLS
XSL•FO
RenderX
(retinopathy, neuropathy, and nephropathy) and macrovascular
complications (myocardial infarction, stroke, claudication, and
angina pectoris). Furthermore, we calculate the number of
consultations, both in specialist health care and primary care.
Sample Size
A statistical power analysis based on the primary outcome
measure (healing time) was performed to decide the number of
participants to be included using PASS sample size software,
version 11 (NCSS, LLC). We powered the study to detect a
difference in mean healing time larger than the selected
noninferiority margin of 1.5 months [44,45], assuming 80%
power, a significance level of .025, and a standard deviation of
3.6 months [46]. The analysis showed that on an individual
level, a total sample size of 184 is needed. Considering an
intraclass correlation coefficient of .02 and an average cluster
size of 10 participants (design effect of 1.18), this number
increased to 217 participants. As we expect an attrition rate of
5%, we aim to include 114 patients in each treatment group.
Statistical Analysis
We will report descriptive statistics of baseline characteristics
for the treatments groups including means and standard
deviations (medians and interquartile ranges for continuous
variables and numbers and percentages for categorical
variables).
Noninferiority of the telemedicine intervention will be confirmed
if the lower limit of the 95% confidence interval for the mean
difference in healing time is less than 1.5 months. To account
for correlated data introduced by the study design, we will apply
the linear mixed-effects model [47] for this analysis. In addition,
we will analyze group differences in time to healing with a
proportional hazards model with adjustment of the standard
error for clustered observations. Secondary outcome measures
will be analyzed with superiority hypothesis tests. These tests
will be based on either (generalized) mixed-effects models [47]
or proportional hazards models (cluster) depending on the type
of the outcome measure investigated. Estimated effect measures
(absolute and relative) will be presented with 95% confidence
intervals and P values.
Because our trial has a maximum follow-up period of 48 months,
we expect some dropouts. We will perform intention-to-treat
analyses and additional analyses based on the participants who




Some participants with diabetic foot ulcers receiving either the
telemedicine follow-up in primary care in collaboration with
outpatient specialist care or standard outpatient care were
individually interviewed to explore their experiences with
telemedicine follow-up or standard outpatient care delivered in
the DiaFOTo trial. Interviewees were selected to ensure a
diverse sample in terms of group (intervention vs control), age,
gender, marital status, setting, and comorbid diseases. The study
nurses at the clinical sites organized recruitment of the patients.
Patients were included if their foot ulcers had healed or after
the intervention was completed.
Data were collected using individual semistructured interviews.
The interview guide contained eight overall topics with
subthemes for the intervention group and seven overall topics
with subthemes for the control group. The topics were similar
for both groups, except the control group were not asked
questions related to the telemedicine equipment and the health
care professional’s attitudes on using images in wound care
(Textbox 1).
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Textbox 1. Main topics in the interview guide (patient experience).
Intervention group
• Patient experience with the foot ulcer and what he/she did when he/she discovered the ulcer
• Patient experience of receiving telemedicine treatment and follow-up from the home care nurse
• Patient experience of being followed up in specialist health care
• Patient experience of being involved in wound management and decisions that concerned his/her treatment
• Patient experience with health care professional use of the telemedicine equipment and health care professional’s attitude on using images in
wound care
• Patient-observed telemedicine collaboration between the home care nurse and specialist health care service during follow-up
• Patient perception of whether he/she takes more responsibility for his/her own health
• Patient perception of the most important task home care nurses and experts at the outpatient clinic have in treatment and care of patients with
diabetic foot ulcers
Control group
• Patient experience with the foot ulcer and what he/she did when he/she discovered the ulcer
• Patient experience of receiving traditional treatment and follow-up from the home care nurse
• Patient experience of being followed up in specialist health care
• Patient experience of being involved in wound management and decisions that concerned his/her treatment
• Patient-observed collaboration between the home care nurse or general practitioner and specialist health care services during follow-up
• Patient perception of whether he/she takes more responsibility for his/her own health
• Patient perception of the most important task home care nurses and experts at the outpatient clinic have in treatment and care of patients with
diabetic foot ulcers
Data were collected and interviews carried out until saturation
was achieved, in line with recommendations existing for
qualitative research [48]. Transcribed interview text was
analyzed by developing codes, grouping similar codes together
in larger groups, and exploring these for patterns in terms of
similarities and differences. As relationships became apparent,
we interpreted them from a clinical and theoretical perspective.
Several researchers were involved to support reflexivity of
researchers throughout all phases of the qualitative study.
Researchers analyzed data separately first and then compared
and contrasted their analyses to reach a consensus on main
themes and subthemes. Interpretive description was used as a
strategy in this study. This approach to qualitative knowledge
development for applied clinical fields aims to produce new
knowledge and a contextual understanding that can be put to
direct applied use when implementing the intervention in future
clinical practice [49,50].
Health Care Professional Experiences
Interpretive description was also used as a research strategy for
this study. Health care professional experiences with the
intervention were explored and Donabedian’s framework was
used to structure essential components of health services to be
addressed in the study [51,52]. Information on health care
professional experiences was collected through focus group
interviews among those working in primary care or in specialist
care delivering the intervention. We mixed different health care
professions within their own working context so that different
perspectives within their context could be explored and
discussed. The focus groups were conducted by a moderator
and comoderator among health care professionals in the initial
stages of introducing telemedicine in their work. The
semistructured interview guide covered topics related to our
study aim (Textbox 2).
Textbox 2. Main topics in the interview guide (health care professional experience).
• Participant experience using telemedicine and how it was organized where they work
• Participant experience using telemedicine as a new tool in documentation and communication
• Participant experience of communication and collaboration between outpatient clinic (physicians, nurses, and foot therapists) and nurses in home
care through telecommunication and among professions
• Participant perception of changes in competence in caring for people with diabetes foot ulcers during the intervention
• Participant perception of changes in job satisfaction while using telemedicine
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All participants receive written information about the project
and its aims with a description of the procedures of the project
before inclusion. We inform participants that their privacy will
be protected and all data will be coded and processed
anonymously to protect confidentiality and that they can
withdraw from the project at any time without this affecting
their treatment. All patients are required to provide written
informed consent before participation. We do not believe that
the project has any negative effects for the patients involved
that would raise problematic or specific ethical issues.
Completing the questionnaire might be a burden, but we do not
consider this burden to exceed the potential new knowledge
and evidence the study will produce. The project is approved
by the Western Norway Regional Committee for Medical and
Health Research Ethics (2011/1609), which also has given
approval for merging our data with the Norwegian cause of
death and sick leave registries.
The Norwegian Centre for Integrated Care and Telemedicine
lent its expertise in data security and legal aspects to the
planning of this project. In line with Norwegian legislation and
security services, data controller agreements were performed
between all parties. We performed risk assessment analyses
after the pilot project and after years 1 and 2 of the trial.
Information about the project has been disseminated in
collaboration meetings at different administrative levels in the
involved municipalities. Qualitative substudies were performed
to include the perspective of health care users. In addition, a
representative from the Norwegian Diabetes Association is
participating in the project group. We have established
standardized procedures for transfer of data, security, and
storage of data in collaboration with the Norwegian Centre for
Integrated Care and Telemedicine.
Results
The study has been successfully funded. The inclusion of
patients started September 2012 from 26 municipalities or
districts. Because recruitment goals were not met in the initial
period, two more hospitals from the Western Norwegian Health
Region have been included to meet sample size requirements.
Patients from Sunnhordland County referred to the department
of surgery at Stord Hospital (Helse Fonna HF) were included
from September 2013 (6 districts), and patients from Hordaland
County referred to the department of orthopedics or
endocrinology unit at Haukeland University hospital (Helse
Bergen HF) were included from November 2014 (10 districts),
for a total of 42 districts before randomization (Figure 1).
Furthermore, patient recruitment has been extended through
June 2016. We expect to present results of the study in 2017.
Data collection in the qualitative substudies has been completed.
Information on patient experiences was collected between March
2014 and May 2015 from 24 participants with diabetic foot
ulcers receiving either the telemedicine follow-up in primary
care in collaboration with outpatient specialist care or standard
outpatient care. Information on health care professional
experiences was collected through 10 focus group interviews
from 7 home-based care services, 2 outpatient clinics, a medical
center, and a nurse-led primary care clinic during 2014 and 2015
(n=43). Focus group interviews lasted from 70 to 90 minutes,
included 3 to 7 health care professionals, and were audiotaped.
The results of these studies are submitted and will be available
in 2016.
Discussion
This project will contribute to increased focus on integrated
care and is in accordance with national strategies [12]. By
transferring the follow-up care to the lowest effective service
level, we anticipate that results of this trial will improve the
motivation and awareness of health care professionals in the
community to implement disease prevention measures. We
believe that telemedicine can become a tool to raise the
competence of nurses in the community and facilitate better
communication and closer collaboration between health care
levels, improving both foot ulcer care and general diabetes care.
In this project, patients are not sending pictures directly to
specialist health care services because it would be difficult for
patients with diabetic foot ulcers to take pictures themselves
due to location of the ulcers, frailty, age, and impaired vision.
However, we expect that telemedicine-based ulcer follow-up
can positively influence patient competence and involvement
in diabetes self-management, including using preventive
strategies to avoid or delay new foot ulcers. If the study finds
evidence of positive health gains for the individuals with
diabetes and contributes to a higher quality of care, this new
model may be applicable to other hospital trusts and health care
regions.
An important concern due to internal validity is whether the
intervention is working similarly in all communities and within
the community itself. The nurses in the community are trained
by using written information. Individual teaching and training
of the nursing staff in primary care is offered at the specialist
clinic or in primary care to secure equivalent and competent
management of patients. We have not made important changes
to the intervention or control arm during the trial, and we used
the same photo documentation (smartphone/camera) throughout
the project. When designing the study we stressed the internal
validity. The rationale for choosing a cluster-randomized trial
was that classic randomization could threaten the internal
validity because nurses in the municipalities would treat patients
in both the intervention and control groups. During the study,
we have used qualitative studies to explore in detail how this
complex intervention is working from a patient and provider
perspective. Results from the trial as well as results from the
qualitative studies will be published in peer-reviewed journals
to the international audit. All studies will emphasize internal
and external validity in line with the Model for Assessment of
Telemedicine criteria [19].
One of the concerns of this complex intervention study is
whether the patients included in the trial are representative of
the majority of patients with diabetic foot ulcers. Patients with
more complex illness living in nursing homes or having mental
problems and those having difficulties traveling to a hospital
may benefit from this type of intervention the most but will be
excluded from participation in the present trial due to their
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vulnerability. In addition, we excluded patients with a previous
ulcer within 6 months of presentation since repeated chronic
ulcers may interfere with the primary outcome. Therefore, our
cohort does not fully reflect the total population with diabetic
foot ulcers attending the participating clinics. To increase the
number of patients included in the trial, the study is embedded
in daily clinical practice at three clinical sites. This will
contribute to increasing the external validity and generalizability
of the results and thus make them more applicable to a realistic
clinical setting.
We expect this project to provide evidence about alternative
care pathways for the treatment of diabetic foot ulcers that may
reduce the cost of health care services by delivering a larger
proportion of services in municipal primary care. This study
may also contribute to setting priorities for patient needs for
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